Dr. Alison R. Walker
Claim this profileMoffitt Cancer Center
Area of expertise
Acute Myelogenous Leukemia
Alison R. Walker has run 4 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:
Acute Myeloid Leukemia
Alison R. Walker has run 2 trials for Acute Myeloid Leukemia.
Affiliated Hospitals
Moffitt Cancer Center
Ohio State University Comprehensive Cancer Center
Clinical Trials Alison R. Walker is currently running
Venetoclax + CLAG-M
for AML
This multicenter, open-label phase II study combines CLAG-based therapy with or without venetoclax in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) in order to improve measurable residual disease (MRD) clearance and event-free survival. Investigators hypothesize that the addition of venetoclax to CLAG-M in patients with relapsed or refractory AML is safe, and superior to CLAG-M alone in improving patient outcomes.
Recruiting
1 award
Phase 2
6 criteria
Discontinuing Decitabine/Azacitidine + Venetoclax
for AML
The purpose of this research study is to see if people whose Acute myeloid leukemia (AML) is being successfully treated with azacitidine or decitabine in combination with venetoclax can discontinue this chemotherapy for some period of time after a year of treatment without increasing the likelihood that their AML will return.
Recruiting
1 award
Phase 2
6 criteria
More about Alison R. Walker
Clinical Trial Related
1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Alison R. Walker has experience with
- Decitabine
- Venetoclax
- Bortezomib
- Sorafenib Tosylate
- Blinatumomab
- Inotuzumab Ozogamicin
Breakdown of trials Alison R. Walker has run
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Burkitt Lymphoma
Childhood Leukemia
Acute Lymphoblastic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alison R. Walker specialize in?
Alison R. Walker focuses on Acute Myelogenous Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved HLA-A positive patients, or patients who are HLA-A negative.
Is Alison R. Walker currently recruiting for clinical trials?
Yes, Alison R. Walker is currently recruiting for 2 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Alison R. Walker has studied deeply?
Yes, Alison R. Walker has studied treatments such as Decitabine, Venetoclax, Bortezomib.
What is the best way to schedule an appointment with Alison R. Walker?
Apply for one of the trials that Alison R. Walker is conducting.
What is the office address of Alison R. Walker?
The office of Alison R. Walker is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.